TG Therapeutics, Inc. Common Stock (NASDAQ: TGTX) last traded at $54.34, down 1.68% on the session. The quote above updates while this page is open; the figures below are drawn from TG Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
TG Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TGTX. Its market capitalisation is $8.32 billion.
Valuation measures for TG Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.32B |
|---|---|
| Enterprise value | $8.87B |
| P/E ratio | 19.83 |
| Price / sales | 10.40 |
| Price / book | 13.77 |
| Beta | 0.49 |
Trailing-twelve-month figures tagged in TG Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $799.54M |
|---|---|
| Net income (TTM) | $441.49M |
| EPS (TTM) | $2.74 |
| Gross margin | 82.37% |
| Operating margin | 17.05% |
| Return on equity | 73.08% |
| Cash | $482.57M |
Range and volume for TGTX over the past 52 weeks.
| 52-week high | $59.30 |
|---|---|
| 52-week low | $26.76 |
| Volume | 1.00M |
| Average volume | 1.99M |
| Previous close | $55.27 |
Invest a chosen dollar amount in TG Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TGTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.